Effects of Aging and Liver Disease upon the Pharmacokinetics of Nipradilol

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.16, Iss.3, 1998-09, pp. : 251-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Liver Disease on Pharmacokinetics: An Update

By Rodighiero V.

Clinical Pharmacokinetics, Vol. 37, Iss. 5, 1999-11 ,pp. : 399-431

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Opioids in Liver Disease

By Tegeder I. Lötsch J. Geisslinger G.

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 17-40

Adis International

Access to resources Recommend Favorite

Cholestasis and Endogenous Opioids: Liver Disease and Exogenous Opioid Pharmacokinetics

By Davis Mellar

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 825-850

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of thiophane upon intragastric administration

By Chernysheva G. Gurto R. Khazanov V. Plotnikov M. Smol’yakova V. Prosenko A. Kandalintseva A.

Pharmaceutical Chemistry Journal, Vol. 44, Iss. 4, 2010-08 ,pp. : 171-174

Springer Publishing Company

Access to resources Recommend Favorite

Liver Disease

By Therapondos George Hayes P C

Clinical Medicine, Vol. 2, Iss. 4, 2002-07 ,pp. : 297-302

Royal College Of Physicians

Access to resources Recommend Favorite